CLOV vs HUM
CLOV: Clover Health combines Medicare Advantage insurance with a data-driven, AI-enabled software platform designed to improve primary care outcomes and manage medical costs. HUM: A prominent managed care organization and provider of Medicare Advantage insurance plans.
Side-by-side fundamentals
| Metric | CLOV | HUM | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $4.58 | $387.12 | |
| Market cap | $2.4B | $46.5B | |
| P/E as of 2026-10-08 | n/a | 36.66 | |
| Net margin FY2025, SEC XBRL | -4.4% | +0.9% | HUM higher |
| Gross margin FY2023, SEC XBRL | +20.4% | n/a | |
| Operating margin FY2025, SEC XBRL | -4.4% | +2.1% | HUM higher |
| ROE FY2025, SEC XBRL | -27.7% | +6.7% | HUM higher |
| ROA FY2025, SEC XBRL | -15.8% | +2.4% | HUM higher |
| Debt / equity as of 2026-09-03 | 0.00 | 0.74 | CLOV lower |
| Revenue growth (YoY) as of 2026-09-03 | +48.8% | +18.3% | CLOV higher |
| Revenue CAGR (3y) SEC XBRL | +20.6% | +11.8% | CLOV higher |
| Dividend yield as of 2026-09-03 | n/a | +0.9% | |
| Dividend streak (yrs) SEC XBRL | n/a | 14 | |
| Beta as of 2026-09-03 | 0.89 | 0.49 | |
| 1-year return as of 2026-10-08 close | +64.7% | +29.9% | CLOV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.